Assesment of the Use of Antibiotics in Patients Pneumonia Inpatients in Sultan Agung RSI Semarang with Method ATC/DDD
Abstract
Pneumonia is an acute infectious disease that attacks the lung tissue, caused by viruses, bacteria, fungi and parasites that cause inflammation of the lung parenchyma and accumulation of inflammation in the respiratory tract. One of the treatments for pneumonia is antibiotics. It is necessary to control antibiotic resistance by evaluating antibiotics. This study purposed to evaluating the profile of antibiotic used in quantitative method to pneumonia patients at RSI Sultan Agung Semarang which was calculated using the ATC/DDD method. This research conducted retrospective cohort with cross sectional design. The sampling technique was used total sampling on 34 Pneumonia inpatients obtained from patient medical record. Subssquently, patient data analyzed by quantitatively using the ATC/DDD method. There are 5 types a single antibiotics used for pneumonia therapy, namely Levofloxacin (50%), Ceftriaxone (14.71%), Moxifloxacin (14.71%), Cefoperazone (11.76%), Meropenem (2.94%), and 2 types was used in combination, namely Loevofloxacin + Ciprofloxacin (2.94%) and Meropenem + Cefotaxime (2.94%). The value of DDD/100 days of hospitalization was 70.5 DDD/100 days of hospitalization with the highest antibiotic, namely Levofloxacin, of 40 DDD/100 days of hospitalization. Antibiotics included in the 90% segment were Levofloxacin (56.74%) and Moxifloxacin (18.71%). The most widely used antibiotic in pneumonia patients is Levofloxacin (50%). The total value of DDD/100 days of…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.